NEI Research News

The K99/R00 provides a runway for postdocs seeking to transition from mentored positions to tenure track positions at academic institutions in the U.S.

A summary of the April 11, 2023, workshop, "NEI-NIMHD Vision Health Equity Workshop," is available on the NEI website.

The National Eye Institute (NEI) is pleased to announce the election of Michael F. Chiang, M.D. to the National Academy of Medicine.

Ruchi Sharma, Ph.D., a staff scientist in the NEI Ocular and Stem Cell Translational Section, received an award from the Knights Templar Eye Foundation (KTEF), a charity sponsored by the Grand Encampment of Knights Templar.

Nitin Verma visited NIH and shared his lifetime perspective on the delivery of vision care to underserved populations in the Australia/South Pacific region—roughly 50-million people scattered across vast stretches of land and ocean.

Researchers have successfully transplanted human microglia into mouse retina to create a model for studying eye disease treatments, such as diabetic retinopathy, glaucoma and age-related macular degeneration.

The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons.

The National Eye Institute (NEI) hosted winners of the 2023 Eye on the Future Video Contest on July 14 on the NIH Campus in Bethesda, Maryland.

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).